X0306 4 2020-05-11 0 0000817720 SYNAPTICS Inc SYNA 0001486742 McFarland John 1251 MCKAY DRIVE SAN JOSE CA 95131 0 1 0 0 SVP, General Counsel & Sec. Common Stock 2020-05-11 4 M 0 3277 45.32 A 24535 D Common Stock 2020-05-11 4 S 0 4251 65.5911 D 20284 D Common Stock 2020-05-11 4 S 0 2343 66.2929 D 17941 D Common Stock 2020-05-11 4 S 0 61 67.14 D 17880 D Employee Stock Option (Right to Buy) 45.32 2020-05-11 4 M 0 3277 0.00 D 2024-08-04 Common Stock 3277 298 D Includes 65 shares acquired under the Issuer's employee stock purchase plan in November 2019 and 20 shares acquired under the Issuer's employee stock purchase plan in March 2020. The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.99 to $65.94, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.99 to $66.86, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of August 4, 2017, with the remaining two-thirds vesting quarterly until fully vested on August 4, 2020. /s/ Kermit Nolan, as attorney-in-fact 2020-05-13